UCL Institute of Ophthalmology


Artificial Angiogenesis Symposium

27 July 2017, 1:30 pm–6:30 pm

Blood vessels and glia in human retina

Event Information

Open to



Marcus Fruttinger


G06 Sir Ambrose Fleming Lecture Theatre UCL Roberts Building Torrington Place London WC1E 7JE

The growth of new blood vessels (angiogenesis) plays an important role in normal physiology as well as in pathology and is therefore the focus of much research. However, this biological process is not easily recreated under cell culture conditions.

Whilst it is relatively easy to induce and study vascular sprouts in vitro, the in vitro development of vascular networks has not been well established so far. This not only hinders basic research into angiogenesis, but also represents a major bottleneck in the field of tissue engineering, where tissues beyond a certain size need to be supported by a network of functional blood vessels. However, in recent years, progress made in bioengineering and microfluidics shows promise and is potentially enabling in vitro modelling of angiogenesis.

In this symposium, we will explore the basic biological conditions required for artificial angiogenesis and some of the emerging tools and technologies that can contribute towards achieving it.



13:00 - 13:00Arrival and registration 
13:30 - 14:00Marcus Fruttiger (UCL Institute of Ophthalmology)General principles of angiogenesis
14:00 - 14:30Qinbo Xu (HF Centre of Regenerative Medicine, King’s College London)Differentiation of stem cells into endothelial lineage useful for angiogenesis
14:30 - 15:00Umber Cheema (UCL, Department of Biochemical Engineering)TBA
15:00 - 15:30Coffee break 
15:30 - 16:00Ivan Wall (UCL, Department of Biochemical Engineering) Priming MSCs for vascular support.=/regeneration in regenerative
16:00 - 16:30Chris Hughes (University of California Irvine) An in vitro model of angiogenesis
16:30 - 17:00Noo Li Jeon (Seoul National University)Angiogenesis in microfluidics devices
17:00 - 18:30Drinks reception (Foyer G02) 

This event is sponsored by the Medical Research Council (MRC) and the Korea Health Industry Development Institute (KHIDI).